188 related articles for article (PubMed ID: 24131980)
1. Liver-directed adeno-associated virus serotype 8 gene transfer rescues a lethal murine model of citrullinemia type 1.
Chandler RJ; Tarasenko TN; Cusmano-Ozog K; Sun Q; Sutton VR; Venditti CP; McGuire PJ
Gene Ther; 2013 Dec; 20(12):1188-91. PubMed ID: 24131980
[TBL] [Abstract][Full Text] [Related]
2. Gene Therapy in Combination with Nitrogen Scavenger Pretreatment Corrects Biochemical and Behavioral Abnormalities of Infant Citrullinemia Type 1 Mice.
Bazo A; Lantero A; Mauleón I; Neri L; Poms M; Häberle J; Ricobaraza A; Bénichou B; Combal JP; Gonzalez-Aseguinolaza G; Aldabe R
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499263
[TBL] [Abstract][Full Text] [Related]
3. Adeno-associated virus-mediated rescue of neonatal lethality in argininosuccinate synthetase-deficient mice.
Kok CY; Cunningham SC; Carpenter KH; Dane AP; Siew SM; Logan GJ; Kuchel PW; Alexander IE
Mol Ther; 2013 Oct; 21(10):1823-31. PubMed ID: 23817206
[TBL] [Abstract][Full Text] [Related]
4. Correction of argininosuccinate synthetase (AS) deficiency in a murine model of citrullinemia with recombinant adenovirus carrying human AS cDNA.
Ye X; Whiteman B; Jerebtsova M; Batshaw ML
Gene Ther; 2000 Oct; 7(20):1777-82. PubMed ID: 11083500
[TBL] [Abstract][Full Text] [Related]
5. Adeno-associated virus serotype 8 gene transfer rescues a neonatal lethal murine model of propionic acidemia.
Chandler RJ; Chandrasekaran S; Carrillo-Carrasco N; Senac JS; Hofherr SE; Barry MA; Venditti CP
Hum Gene Ther; 2011 Apr; 22(4):477-81. PubMed ID: 20950151
[TBL] [Abstract][Full Text] [Related]
6. Citrullinemia type I is associated with a novel splicing variant, c.773 + 4A > C, in ASS1: a case report and literature review.
Lin Y; Gao H; Lu B; Zhou S; Zheng T; Lin W; Zhu L; Jiang M; Fu Q
BMC Med Genet; 2019 Jun; 20(1):110. PubMed ID: 31208364
[TBL] [Abstract][Full Text] [Related]
7. Lethality rescue and long-term amelioration of a citrullinemia type I mouse model by neonatal gene-targeting combined to SaCRISPR-Cas9.
Lisjak M; Iaconcig A; Guarnaccia C; Vicidomini A; Moretti L; Collaud F; Ronzitti G; Zentilin L; Muro AF
Mol Ther Methods Clin Dev; 2023 Dec; 31():101103. PubMed ID: 37744006
[TBL] [Abstract][Full Text] [Related]
8. Identification of three novel mutations in fourteen patients with citrullinemia type 1.
Kose E; Unal O; Bulbul S; Gunduz M; Häberle J; Arslan N
Clin Biochem; 2017 Aug; 50(12):686-689. PubMed ID: 28132756
[TBL] [Abstract][Full Text] [Related]
9. Early prediction of phenotypic severity in Citrullinemia Type 1.
Zielonka M; Kölker S; Gleich F; Stützenberger N; Nagamani SCS; Gropman AL; Hoffmann GF; Garbade SF; Posset R;
Ann Clin Transl Neurol; 2019 Sep; 6(9):1858-1871. PubMed ID: 31469252
[TBL] [Abstract][Full Text] [Related]
10. Transient fulminant liver failure as an initial presentation in citrullinemia type I.
Faghfoury H; Baruteau J; de Baulny HO; Häberle J; Schulze A
Mol Genet Metab; 2011 Apr; 102(4):413-7. PubMed ID: 21227727
[TBL] [Abstract][Full Text] [Related]
11. Functional analysis of novel splicing and missense mutations identified in the ASS1 gene in classical citrullinemia patients.
Kimani JK; Wei T; Chol K; Li Y; Yu P; Ye S; Huang X; Qi M
Clin Chim Acta; 2015 Jan; 438():323-9. PubMed ID: 25179242
[TBL] [Abstract][Full Text] [Related]
12. Modelling urea-cycle disorder citrullinemia type 1 with disease-specific iPSCs.
Yoshitoshi-Uebayashi EY; Toyoda T; Yasuda K; Kotaka M; Nomoto K; Okita K; Yasuchika K; Okamoto S; Takubo N; Nishikubo T; Soga T; Uemoto S; Osafune K
Biochem Biophys Res Commun; 2017 May; 486(3):613-619. PubMed ID: 28302489
[TBL] [Abstract][Full Text] [Related]
13. Asymptomatic ASS1 carriers with high blood citrulline levels.
Chen HA; Hsu RH; Chang KL; Huang YC; Chiang YC; Lee NC; Hwu WL; Chiu PC; Chien YH
Mol Genet Genomic Med; 2022 Sep; 10(9):e2007. PubMed ID: 35726796
[TBL] [Abstract][Full Text] [Related]
14. Extracellular vesicles from human liver stem cells restore argininosuccinate synthase deficiency.
Herrera Sanchez MB; Previdi S; Bruno S; Fonsato V; Deregibus MC; Kholia S; Petrillo S; Tolosano E; Critelli R; Spada M; Romagnoli R; Salizzoni M; Tetta C; Camussi G
Stem Cell Res Ther; 2017 Jul; 8(1):176. PubMed ID: 28750687
[TBL] [Abstract][Full Text] [Related]
15. Mutations in the Human Argininosuccinate Synthetase (ASS1) Gene, Impact on Patients, Common Changes, and Structural Considerations.
Diez-Fernandez C; Rüfenacht V; Häberle J
Hum Mutat; 2017 May; 38(5):471-484. PubMed ID: 28111830
[TBL] [Abstract][Full Text] [Related]
16. Citrullinemia Type 1: Behavioral Improvement with Late Liver Transplantation.
Janwadkar A; Shirole N; Nagral A; Bakshi R; Vasanth S; Bagde A; Yewale V; Mirza D
Indian J Pediatr; 2019 Jul; 86(7):639-641. PubMed ID: 30848473
[TBL] [Abstract][Full Text] [Related]
17. ASS1 deficiency is associated with impaired neuronal differentiation in zebrafish larvae.
Seidl MJ; Scharre S; Posset R; Druck AC; Epp F; Okun JG; Dimitrov B; Hoffmann GF; Kölker S; Zielonka M
Mol Genet Metab; 2024 Jan; 141(1):108097. PubMed ID: 38113552
[TBL] [Abstract][Full Text] [Related]
18. Liver-directed recombinant adeno-associated viral gene delivery rescues a lethal mouse model of methylmalonic acidemia and provides long-term phenotypic correction.
Carrillo-Carrasco N; Chandler RJ; Chandrasekaran S; Venditti CP
Hum Gene Ther; 2010 Sep; 21(9):1147-54. PubMed ID: 20486773
[TBL] [Abstract][Full Text] [Related]
19. Targeted modifications in adeno-associated virus serotype 8 capsid improves its hepatic gene transfer efficiency in vivo.
Sen D; Gadkari RA; Sudha G; Gabriel N; Kumar YS; Selot R; Samuel R; Rajalingam S; Ramya V; Nair SC; Srinivasan N; Srivastava A; Jayandharan GR
Hum Gene Ther Methods; 2013 Apr; 24(2):104-16. PubMed ID: 23442071
[TBL] [Abstract][Full Text] [Related]
20. Generation of a mouse model for citrullinemia by targeted disruption of the argininosuccinate synthetase gene.
Patejunas G; Bradley A; Beaudet AL; O'Brien WE
Somat Cell Mol Genet; 1994 Jan; 20(1):55-60. PubMed ID: 8197477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
